IDEXX Laboratories Inc
NASDAQ:IDXX

Watchlist Manager
IDEXX Laboratories Inc Logo
IDEXX Laboratories Inc
NASDAQ:IDXX
Watchlist
Price: 471.9 USD 0.11% Market Closed
Market Cap: 38.2B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one IDXX stock under the Base Case scenario is 312.57 USD. Compared to the current market price of 471.9 USD, IDEXX Laboratories Inc is Overvalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDXX Relative Value
Base Case
312.57 USD
Overvaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.9
P/S
P/S
Price to Sales
9.9
vs History
74
vs Industry
14
Median 3Y
10.4
Median 5Y
11.6
Industry
2.2
Forward
9.2
More Details
43.4
P/E
P/E
Price to Earnings
43.4
vs History
82
vs Industry
14
Median 3Y
47.5
Median 5Y
54.4
Industry
21.9
Forward
38.9
More Details
41.5
P/OCF
P/OCF
Price to OCF
41.5
vs History
80
vs Industry
9
Median 3Y
48.3
Median 5Y
56.6
Industry
13.5
More Details
85.1
P/FCFE
P/FCFE
Price to FCFE
85.1
vs History
38
vs Industry
6
Median 3Y
74.5
Median 5Y
78.8
Industry
19.3
More Details
24.1
P/B
P/B
Price to Book Value
24.1
vs History
87
vs Industry
2
Median 3Y
31
Median 5Y
59.1
Industry
2.1
More Details
10
EV/S
EV/S
Enterprise Value to Sales
10
vs History
76
vs Industry
14
Median 3Y
10.5
Median 5Y
11.9
Industry
2.3
Forward
9.3
More Details
16.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
16.4
vs History
79
vs Industry
13
Median 3Y
17.5
Median 5Y
20
Industry
4.8
More Details
30.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.8
vs History
84
vs Industry
11
Median 3Y
33.8
Median 5Y
38.3
Industry
11.5
Forward
26.8
More Details
34.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
34.4
vs History
82
vs Industry
14
Median 3Y
37.3
Median 5Y
42.5
Industry
15.6
Forward
30
More Details
41.9
EV/OCF
EV/OCF
Enterprise Value to OCF
41.9
vs History
80
vs Industry
9
Median 3Y
48.9
Median 5Y
58
Industry
13.3
More Details
48.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
48.8
vs History
82
vs Industry
10
Median 3Y
59.8
Median 5Y
72.3
Industry
17.3
More Details
13.5
EV/IC
EV/IC
Enterprise Value to IC
13.5
vs History
79
vs Industry
6
Median 3Y
14
Median 5Y
16.2
Industry
1.8
More Details

Multiples Across Competitors

IDXX Competitors Multiples
IDEXX Laboratories Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.5B USD 9.9 43.4 30.8 34.4
US
Abbott Laboratories
NYSE:ABT
230B USD 5.4 17 22.1 31.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD 21.6 76.2 60.8 73.1
US
Boston Scientific Corp
NYSE:BSX
154.7B USD 8.8 76.1 35.9 49.7
US
Stryker Corp
NYSE:SYK
144.3B USD 6.4 48.2 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
108.9B USD 3.3 25.6 13.7 19.3
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR 2.4 27 15.6 22.2
US
Becton Dickinson and Co
NYSE:BDX
48.9B USD 2.4 28 12.5 22.5
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8 10.7 24.4 26.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
266.3B CNY 7.5 23.9 20.9 20.9
US
Resmed Inc
NYSE:RMD
35.2B USD 7 26.8 19.1 21.7

See Also

Summary
IDXX intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDXX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDXX stock valuation using valuation multiples.
Wall Street Estimates
IDXX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDXX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 252,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.